ASTAGRAF XL is a Oral Capsule, Coated, Extended Release in the Human Prescription Drug category. It is labeled and distributed by Astellas Pharma Us, Inc.. The primary component is Tacrolimus.
Product ID | 0469-0647_4b0d99f4-01fe-47b4-a447-70c996917f4a |
NDC | 0469-0647 |
Product Type | Human Prescription Drug |
Proprietary Name | ASTAGRAF XL |
Generic Name | Tacrolimus Extended-release Capsules |
Dosage Form | Capsule, Coated, Extended Release |
Route of Administration | ORAL |
Marketing Start Date | 2013-07-19 |
Marketing Category | NDA / NDA |
Application Number | NDA204096 |
Labeler Name | Astellas Pharma US, Inc. |
Substance Name | TACROLIMUS |
Active Ingredient Strength | 1 mg/1 |
Pharm Classes | Calcineurin Inhibitor Immunosuppressant [EPC],Calcineurin Inhibitors [MoA] |
NDC Exclude Flag | N |
Listing Certified Through | 2022-12-31 |
Marketing Start Date | 2013-07-19 |
NDC Exclude Flag | N |
Sample Package? | N |
Marketing Category | NDA |
Application Number | NDA204096 |
Product Type | HUMAN PRESCRIPTION DRUG |
Billing Unit | EA |
Marketing Start Date | 2013-07-19 |
Marketing Category | NDA |
Application Number | NDA204096 |
Product Type | HUMAN PRESCRIPTION DRUG |
Marketing Start Date | 2013-07-19 |
Marketing End Date | 2019-06-24 |
Ingredient | Strength |
---|---|
TACROLIMUS | .5 mg/1 |
SPL SET ID: | 550a5cd4-fbf2-4c09-b577-6bde8fcbdf6e |
Manufacturer | |
UNII | |
RxNorm Concept Unique ID - RxCUI |
NDC | Brand Name | Generic Name |
---|---|---|
0469-0647 | ASTAGRAF XL | tacrolimus extended-release capsules |
0469-0677 | ASTAGRAF XL | tacrolimus extended-release capsules |
0469-0687 | ASTAGRAF XL | tacrolimus extended-release capsules |
Mark Image Registration | Serial | Company Trademark Application Date |
---|---|
ASTAGRAF XL 85925271 4480263 Live/Registered |
Astellas Pharma Inc. 2013-05-07 |